Silvia Dossena Selected Research

Pendred syndrome

1/2013	A FRET-based approach for quantitative evaluation of forskolin-induced pendrin trafficking at the plasma membrane in bronchial NCI H292 cells.
1/2011	The ESF meeting on "The proteomics, epigenetics and pharmacogenetics of pendrin".
9/2009	Functional characterization of wild-type and mutated pendrin (SLC26A4), the anion transporter involved in Pendred syndrome.
11/2008	Functional assessment of allelic variants in the SLC26A4 gene involved in Pendred syndrome and nonsyndromic EVA.
9/2007	High phenotypic intrafamilial variability in patients with Pendred syndrome and a novel duplication in the SLC26A4 gene: clinical characterization and functional studies of the mutated SLC26A4 protein.
1/2006	Fast fluorometric method for measuring pendrin (SLC26A4) Cl-/I- transport activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Silvia Dossena Research Topics

Disease

6	Pendred syndrome 01/2013 - 01/2006
4	Deafness (Deaf Mutism) 09/2016 - 01/2006
4	Goiter 01/2013 - 01/2006
4	Sensorineural Hearing Loss 11/2008 - 01/2006
3	Inflammation (Inflammations) 10/2022 - 01/2022
2	Hearing Loss (Hearing Impairment) 01/2018 - 07/2010
2	Autosomal Recessive 4 Deafness 01/2018 - 11/2008
2	Bites and Stings (Sting) 01/2018 - 06/2014
1	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2021
1	Diabetes Complications 01/2020
1	Diabetes Mellitus 01/2020
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2020
1	Parkinson Disease (Parkinson's Disease) 01/2019
1	Lewy Body Disease (Lewy Body Dementia) 01/2019
1	Asthma (Bronchial Asthma) 01/2017
1	Respiratory Hypersensitivity 01/2017
1	Nonsyndromic Deafness 09/2016
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2015
1	Atherosclerosis 01/2015
1	Dyslipidemias (Dyslipidemia) 01/2015
1	Type 2 Diabetes Mellitus (MODY) 01/2015
1	Insulin Resistance 01/2015
1	Pain (Aches) 06/2014
1	Drug-Related Side Effects and Adverse Reactions 02/2013
1	Alkalosis 01/2013
1	Adenocarcinoma 02/2012
1	Neoplasms (Cancer) 02/2012
1	Kidney Calculi (Kidney Stone) 07/2010
1	Hypothyroidism 01/2006
1	Hypotension (Low Blood Pressure) 05/2005
1	Mesothelioma 02/2004

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2005
5	AnionsIBA 10/2022 - 02/2004
4	IodidesIBA 01/2013 - 09/2007
2	Erythrocyte Anion Exchange Protein 1 (Band 3 Protein)IBA 10/2022 - 01/2022
2	C-Reactive ProteinIBA 10/2022 - 01/2015
2	ChloridesIBA 01/2022 - 01/2006
2	Bicarbonates (Hydrogen Carbonate)IBA 01/2022 - 01/2013
2	Protein Isoforms (Isoforms)IBA 03/2021 - 01/2019
2	Lidocaine (Xylocaine)FDA LinkGeneric 01/2018 - 06/2014
2	Acetic Acid (Vinegar)FDA LinkGeneric 01/2018 - 06/2014
1	Biological ProductsIBA 03/2021
1	PPAR gammaIBA 03/2021
1	Connexin 26IBA 01/2018
1	VenomsIBA 01/2018
1	Interleukin-13IBA 01/2017
1	Bronchodilator Agents (Bronchodilators)IBA 01/2017
1	Theophylline (Theon)FDA LinkGeneric 01/2017
1	Sterol Regulatory Element Binding ProteinsIBA 06/2015
1	LipidsIBA 01/2015
1	Messenger RNA (mRNA)IBA 01/2015
1	Insulin (Novolin)FDA Link 01/2015
1	Local AnestheticsIBA 06/2014
1	AmmoniaIBA 06/2014
1	AlcoholsIBA 06/2014
1	Ethanol (Ethyl Alcohol)IBA 06/2014
1	CurcuminIBA 02/2012
1	Calcium OxalateIBA 07/2010
1	Membrane Transport Proteins (Biological Pump)IBA 11/2008
1	SaltsIBA 05/2005

Therapy/Procedure

1	Traditional Medicine (Folk Remedies) 01/2018
1	First Aid (Aids, First) 01/2018
1	Precision Medicine 02/2013